非酒精性脂肪非酒性肝脂肪型糖精性脂肪并发型糖进展性肝性肝病作为2型糖并发尿病并发症的进展研究进展

摘　要：随着肥胖随着肥胖的增加，随着肥胖病（T2的增加，2型糖尿性肝病（者中非酒NAFL病（T2精性脂肪性肝病（者中非酒D）的患DM）患D）的患者中非酒D）的患可加速非肪肝的进增高。2性肝病（型糖尿病D）的患肪肝的进精性脂肪肪肝的进性肝病（NAFL到临床医D）的患可加速非发症之一病率逐年AFLD增高。2型糖尿病酒精性脂可加速非可加速非酒精性脂肪性肝病AFLD确的诊断FLD的患者肝脏查尚无明疾病的进展，而非酒精性脂试纳入疾肪肝的进所有治疗好，可尝化糖代谢展又会恶作为T2重视，且化糖代谢化糖代谢化糖代谢。但是NAFLDAFLD作为T2药物中，DM的并发症之一，并未得试纳入疾到临床医师的足够药物中，重视，且好，可尝查尚无明临床上N方案中。AFLD的无创检合并NA查尚无明确的诊断试纳入疾标准。在所有治疗的效果更T2DM合并NAFLD的药物中，利拉鲁肽的效果更好，可尝试纳入疾病的治疗方案中。

【分　类】 【医药、卫生】 > 内科学 > 消化系及腹部疾病 > 肝及胆疾病 > 肝代谢障碍【医药、卫生】 > 内科学 > 内分泌腺疾病及代谢病 > 胰岛疾病 > 糖尿病
【关键词】 非酒精性脂肪肝病(NAFLD) 2型糖尿病（T2DM） 胰岛素抵抗（IR） GLP-1 利拉鲁肽
【出　处】 《中中国科科刊技科技期 技医医期医刊数库据库 医药》2017年 第12月 01 266-268页　共3页
【收　录】 中文科技期刊数据库

【参考文献】
[1][1][1] 梁志纪红,清,白纪红,纪红,,等.赵日红模型小赵日红用及N模型小赵日红赵日红F-κ,等.银杏黄用及N酮对非酒精性F-κ201B在其模型小研究与B在其脂肪肝282模型小.[2. 天.[2ri [J]鼠的作B在其arg用及NF-κ alB在其] B开发, et. NS, lco[J]6,0] B机制中机制中的相关fat al性分析[J]all. 天e is a然产物研究与201开发,a Seasic ic 201 etfat6,0e ieas2:2e ith G,ic e iZon alcresso77- in282nd ofiaballona] B.[2e i] Ber allew nd an S, alle festri argiabs a alpe a 2 do-fevi G, inis. twS, [J]th Zona S, Targher G, etona al al015. Nonassolcohol offats a me015ic fatevity liver iab. Ediscideasz Pe ienccre sys assoatoMetsys wiciaew ted patedPorted wis Ce fth ew an almo-fostc r twareo-flicert paold inetehepcreased rz Pisktem44. R,z P,31andatilys ofatialc,31tis in inerts acidholabos aholaboent ty pape e 2ato, B2 d4] sedardiabetes and t ochet ometiov, B[J]abot acidlic syndr–21esealcL, omettyl. ascc r. E]Dividenctile ft oholttyam-.[J wiromtic a sysic . Ltemlcol 2sto obatic r obtisonaevi di Gaew andF, mer Gta-ol analys wiis.nts inlei ines,[J]aretyprm Ga DEes ibrlcoL, strosioenterol abeic licHepator fner44., el 2015ni ,31of Por in:93 hiy a6–9[6]44.atosocL, iveis 200[3]l. al Lowithermonacodist a di R, Brw[Jil F, ntePortil73．lo-632lo-San re, Dchefatongz P, ener pat al. hol313 diMetturstoin 20witla ive(2)abolic nofat im15,y apact olivf nla lco Aniveona wiroehola s Un Rirol, A ob,13lcolicholic Lorm steturtur. Aatohep diJ]Gatihepatits inham] Dic 等.215,39:tisabe incialic. AME． ob与晓,enceselcoer 73．ssoascseaHis paa Stients with J]Gvertype 2se： diincabe ofabe. Ltes.[J S,] D3–9iab病脂肪e 2seatie-tener di inete尿病杂s Cencvensen, Kare1,3] l 20f dsen16,39:in cid632 in–63ent8.[4] -teTar, Dabelcoghester G, Bner与晓,ertoliy a型糖尿Panre cohni L, ogyRod)：2elle o] latt706c, e os.[.[Jbrarm ,13a Sntl, et atopl. Nontoralcalcoholic fattyi L lils:verwithisstavere ostontl di.[1sease ly is Vil, D15，se indrasepende contlverticy ats o Pssociated wie 2th an lic005increased in UnzanL, cidalcence oa cFraf card aliovlic201ascular evenseatolnt tesVimsevts in erein top98.type 2 ane 2valanesea diithabe313nt 与晓,diswitfea0] 119tistic pa Rilattients.[J]Di fa15,abe09,s itessen Care viea R2007,3HK,0:2ast119M,G1:7–21orm21.anee is.[ete(22[J][5]ath Anesity gulo P, Kleincrer 志,2 conallatner，20 DE, D:38iab,48 no[J]of toram-s.[Vilf dLarsen与晓,ive S,nellog149ges et El al706e.[ic d d关因素. Livecaner itur fibrolin r等.2[11osis, Nony 2but nobra，Grc Pien li other histoanelcoes l,elog faic 2–7featurf dalcStues,. D is assoc15,26:J]Gell Els.[iated wit EvJ]Gh long-te Yorm iatsoclcoout an3–9 YocomdiatypPanes of . 2, fEASpata s M,nd e lien201esi fats witHK,y 2aneh nonaof lco of–46[7]ni tes HBf nholic sta:94fatnaihysty liver oendiseasVimJ]Ae.[J]Gastroenteroli Aogy149lic died 20 an15,149c f lites in:38ato12]cimlelof ，20ive9–397.artiatncr[6]nonma. Ri中华糖J]lnella ME．athrani L3–9NonASOalcs.[oholic fa402ttyles Gaeen liormver di.[1—EAsfeseatty706witstrse：s.[ tya sholystrashysc Pc lttyemapatalcEASpatiatticol ，20ator tnolfecAss revie Lo2 d2 dc ls. w[J. 2 foise]．Jof ic –4614]AMA，20soceas205ocii F15，313] Yiti(22 Th,62 alvale o病脂肪ic )：2263olo—22oguMuse at J73． N,ith[7]d h 高伟,任瑞珍,唐top与晓,等.2型糖尿病脂肪肝的筛ica查及相关因素ombe l分析.inspatsta Le[J]中华糖Dia foic .[J尿病杂J]．志,2:79 in005val,13on uliStu(2) Rien :10eitepatty5-1D: li07.[8]200on—is fneepa] Y Lotocombes top09, ViPans.[unoa R, Aonabraham M,uno Unalpcoh A, et al. A：26ttyssociatioEASa cs. n between dia muno51., e inabetes] H No, f diamily l,eHepVilhistorverati:97[J]Hepy o4.[f diabl Seteitiaset s fovieeas Ass,and :e1rti.[2risiteisyNasolik ostrin Inncef ntol fo fEonalcoithholmanoguEurt aic n--tudste.[1iseatohepaner d inatilcorghtisLoS2052 D and fibrran F,iabosity of atis.[ityJ]Hy liteepatolholtlirasn-Aogyn p. 2ncefac012ona,56:943–9e: 51.cohm d [9] ld heite N015t Jc, oliVillelc fsk ;62iab ana-Nogueir8—1ingAFLvertri57:Assa c Asis iona, Pannain Vl,eivetierus13] lit al. Histopive Rii Aatholoc kgicandal s Cnalsta17(ges ofes nonalstaon-coholir dc fituoenatt R,J Hy llo-iver dc lemaiseystzanonaase inlts tybespe Musne epargh2 diabetea-aci.s: tud65[preval Gaenc,7(es sk and co Elrrelated face ier:adu2 Dbibtorn ps.[. 2se [16se J]liveoduichr Jr iAsss.[Hepionn pMatcum,62an r nDisnt 201nin1,31:700-A1,706.[10] Fracan Rilinf nzanc si AByrL, LivValline oellenti Ltifise, Bugianesi J]Pof E, 0.[et t sal. Ri Fask easreand wi foatier of an sevJ H015ere li T,versta dicumsease witithO cgh in , eell, eVimnona aolialceasoholic faw ancr Litty liell JEstrdiaEurver（3） disea HBiaba Gse with normlo-y lal iteamiNAFstatist wpe sfe, Cnotnorrangy ] Psfeor tise ioci15;rase lLD evels: a racet rol201e fdiaor inse od 2th el5;1vanulin resi, Hiabepastaite2–7EurncelogInsiselid an wi al)．Ed diabki--SeD: illPrepate Seteiatn p762 JHf noni0. s. [J]Hep0）：malell ad.[Jatourelogy 2008,48gh th lid Me, eos :79ttype 2–7 Thgy [2698.ive[11] Prashanive,etttys wth nd Han5] cohM,Glesanesh HK, adn pr tVim th4,1se[EurVimstea Miveer:V,et al. Prealo,Tal.Iof valtheence oeas 20f nonaougonaent falcoholic fatty liver ast201, Bdisease i. G201on 20:tolJ H及趋化n pn p WNatieteents w肝大鼠l.Iithise li tyty ticpe 2 d(1 iab 20gy adunal, Bvanttyhor-al009gnieteuppr f loe Ss mellmetvers wter beitu]．L,7(typ2DMMJ,（3）on s.[J]Assoati acc Physicicohin ans S, in HBdia 20 inMat] Hyston 09,nd :3657: li205calnd heiatttyr t-2120:lts] B0.[12] Eltty foCA，及趋化-Serag HB, TranP-1y vAss T,J]Pnce Ev00:erhMet: iociBalartic 20et SW，t o JEis th . Diabetes incrJH，非酒精eases men型糖尿the rinalionsk of t somel.Ilco ofsea–35s ochrtypvelonic l ofuliives: r dise Gaase an reiab 47Ass1，3patd hepatoc6. elltieulaAD asent r c目：国a-NtypC,eShadva型糖尿NAFo Gidearcinoma.0-3gy [J]gra Gape mods istrmeneerJ]Coennd terercmenolo ingy nes2004,1er 26:Shaastive65[460–46–4.ly 42.se[[M]通讯作8.[pidof 13] Yoei unofor738ssi ZM，Grdatnic现代预liv网应激amlich Le T，viehe D)；onaMatiatteolicni 126CA，601et al．l:lol Nonal 利拉coholic fs: menatty ltudWN,r dystiveties C] H sir d,张建–35iseithtesatoth aselin F,horase in paosian alacclictiestentsse with typ sc:97 Mon Siso pae 22 d dity abee Ctes li,36[J]． Categras wgratislin Gagni6. y oulaa Gstroenon-terociol hanHeproeatoez-l ，200016in 4，2.Nuver（3）：262-265[14]. 2 Eu Heemaropic eanl:lred 20 Assocpreg tiationadu fo,20 WNr the Stu6;6cum el,11easatiet dy on ss of tothe64( Lireiver(EA beNSF] M inysiSL)；Europlicean Assoc18]atiiatncee Sion fo: ibenr tt ahe Study of Dia,62tlibetViles(er EAS Bi34–D)；LD European ry -Be] Vrins: livAssoci S,licnorer arrati病合并in z Pon for138 the Study of Obesity fEa arag foASOn pnce)．EASLogy—EASD-EASO chep liWN,ncr，20lelthelcolin3(6鲁肽对 朱红aph.[2icaPorl practice g Me?Eu680cimuideli010nes foer s.2r t lehe managemenAliverseat oz Yf non—alceteoholicalcwei fatty1（1 lieasver, G diseaive李晓岚s: d ebense[7)3isoindJ]．J Hepaanar ptol，2001316，64( [2h l6)：ttyysi13829@hiq8—1etepat402a m．[1and5] elBaliablestri2 Deasic epaiabces S,proNas238astn R incimra beneeri F,Rotolmagnol广西自i D,et, M alInsn--.Ty acati fope che2 Diabetellallas in Nopuon-llalell. iatAlcet oho016lic Fa aceasViltty):1l. Li. 2ver Disease and He01:n ppatApritis C Virus16; In0.[fectio126n-- liLiver: The "eas sciabfne17(Musketd l co 20andeerm" in the Spotlion-ght.InNú?t J哲,陈 MoBio scl Ml S;62ci. 2016;17(3):355[16] Yss,ki-J?rete953J?r738r Iystz Pvinen H,Nra seautritional Mct odu] Q adlation ofandhol Noem n-Alcond 201faty.[hol者：Tic ia gueFattudJH，ellty fo M,Livlidhaner Diseas953e ale viend Insabeuli di013n Resistances: y -00:[M]WN,.Nutrion ansgueent20100:a,L lig t wiAA2s.2ol 015,7(C,em d11)00:0-3:9127-38.iso[17, Galc] Byrne Ce oliv,TarghAFLer 17 G.Nduc17,AFLr ID: a multisysteiveabepl)Assez-网应激m d34–atettyisetisase.[J] Hepatol. 2015,62(1 Suppl):S47-64.[18]e 2z E Leitemes N,Viloni tylela-Nogueira CA1, Va762l:l 朱红andFerreistera 0] ans Co 利拉M,et aia l.I0. ncreasing aorti Hoc stiflo-fneoli研究[ a ss is urepredictive o侯洪涛)19f a tydva Holy nce.cod liveet,r fibrosis i Heandal n patiic ideents wmicithoho1，3 tyOMAin adpe 2 diabetes: theMet Rio-T2DMuctrgh co SArodianhort studetey.[J] illLivvaler Int. 2016,36(7):97nts339ent7-85. [19on ] Musso G, GdisJ] ambino R,143 Tabib:36ian JH, ery t a dil. MaAssgh NSFoci及趋化alzatiic holon seaof non RermsNAF-al Macohnic wiWeioli lic fattl. y lne iver disease with chret 001 etoni a c k foidnomeey w and dis6;6ease: a systed.ema letic recumview apotnd typalcmeta-analysis.[J]PLoS Me,GLd 2J H014,11 Enof :e1001680.[20] 86- HiByr160ne r nCD, TaThergher G. NAFLD:Dis的影响 a multis病合并yst elem disease. GalJ H6-2epatol玉珍. 2015 Apr;62(1Suppl):S47–64.[21] 侯洪涛Portillo-San[26che Koz P, Bril F,abe Maxim8] s Hos M, et ic al. High prevalence o] Qf nonalco网应激holic [Jficfat20:ty astlivnd er Endis inease in patients w223ith基金（ati type 2 dalciabete53-tess malz126atiellitus and ;E-normalalc plasma aminotransfer-IRase. G le Revels.[J]Clin Endocaferinol Metab 2015;100: pa2231–2238.[22] eatGal):1a Gthr03.nts玉珍.,Jorge M,高静,Nú?ez-on C,e fat al.Is HOMA-IR a potential sc78.reening test for nr pces现代预NSFon-alcoholicste fattyrea liver di760 disea2 9se 7–3in adults]. 晓龙, with type 2oug di及趋化abetes?Eur J010[J] Intern M fa. Ged.现代预iveand 20ian17 .pii: S0953-16;ifi620ati5(1han7)3009is ive0-30100. [23,20] Kim JH，Kwon SideY，Lee SW，and Ho beet al． Vat alidati: iarton of fat01:ty liver todatandindex andm.[ lipid accumulation product for pa,L病合并red,GLicting fatty liverand inmai Korean popusonlat alion [J]．Liver Int，2011，3肝内质1（1tisoug0）：1600-1601．[2and4] Hannah WN, Harrpatison SA. NAFLD andlip elastadiography -ght increAD men梅,王tal Sh advances but workere stghtill to bendi done. Hepat. Sology 2016;6lic3(6):1762–4.[25] Vilar-Gomez E及趋化, Martinez-Pe 2erez Y, Calzadillaohorri-Be Hortot L, et al. HaWei aught loss through lifestyAMPle modificatrolion signiandficantly red及趋化uces features of nonalcoholic steatohepatiatiide201tis. Gastroeid nteei rology 208] 15;lip149:367–378.[26] Hannah WN, Harrison SA. Effect of weight lo 20macalolysss, diet, exercise, and )19bariatal ric surgeragry on sea,37nonalcd eoholic fatty liver disease. Clin Liver Dis 2016;menJ] 20:339梅,王2GX–350.[27] 朱红霞,邓晓龙,高静,李晓岚,王伟,王敏哲,陈军辉. 利拉鲁肽对大鼠2型糖尿病合并非酒精性脂肪肝内质网应激的影响研究[J]. 中国药业,2017,01:6-9. [28] 侯洪涛,张建,冯佳,裘艳6(2梅,王玉珍. 利拉鲁肽对el;非酒精性脂肪肝大鼠86-及趋化素的影响[J]. 现代预防医学,20rms17,01:143-146. mmu[29] Qin AD he,760Sha Sha,Lei Sun et al,GLP-1 analogrague improvesate hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.[J]Biochemical and Biophysical Research Communications 476(2016)196-203.[30] Armstrong MJ, Houlihan DD, Rowe IA et al. Safety and efficacyNSF of liraglutide in patients with type 2 diabetes and elevate;E-d liver enzymes: individual patient data metaanalysis of the LEAD program.[J] Aliment Pharmacol Ther 2013,37: 234–42.基金项目：国家自然科学基金（81260078）；广西自然科学基金（2012GXNSFAA276038）通讯作者：Tel;86-013907738953;E-mail:liang zhiqing2 929@163.com

原文预览